Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?

<p>Abstract</p> <p>Background</p> <p>The increasing use of erythropoietins with long half-lives and the tendency to lengthen the administration interval to monthly injections call for raising awareness on the pharmacokinetics and risks of new erythropoietin stimulating...

Full description

Bibliographic Details
Main Authors: Weibel Nadir, Rigamonti Fabio, Forni Valentina, Nobile Filippo, Gabutti Luca, Burnier Michel
Format: Article
Language:English
Published: BMC 2011-02-01
Series:BMC Nephrology
Online Access:http://www.biomedcentral.com/1471-2369/12/11